Filtered By:
Condition: Heart Disease
Education: Study
Procedure: Heart Valve Surgery

This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 146 results found since Jan 2013.

Sevoflurane alleviates myocardial ischemia/reperfusion injury via actitation of heat shock protein-70 in patients undergoing double valve replacement surgery
This study investigated the cardioprotective effect(s) of sevoflurane in rheumatic heart disease patients undergoing double valve replacement surgery (DVRS) under cardiopulmonary bypass (CPB) and its potential mechanisms (ChiCTR2100051220 on http://www.ChiCTR.org.cn). Forty-six patients were randomly assigned to undergo propofol or sevoflurane anesthesia during surgery. The levels of myocardial injury markers, inflammatory cytokines, heat shock protein-70 (HSP70), and superoxide dismutase (SOD) activity were measured from blood samples. Mean arterial pressure, cardiac index, and stroke volume index were significantly highe...
Source: American Journal of Translational Research - September 15, 2022 Category: Research Authors: Yue Shan Kai Xie Qifu Zhou Rui He Zhonghua Chen Weizhong Feng Source Type: research

Transcatheter aortic valve replacement with or without anesthesiologist: results from a high-volume single center
Conclusion In patients at low or intermediate risk undergoing transfemoral TAVR, a safe procedure can be performed under local anesthesia without the presence of an anesthesiologist in the catheterization laboratory.
Source: Journal of Cardiovascular Medicine - November 12, 2022 Category: Cardiology Tags: Research articles: Valvular heart disease Source Type: research

Subannular repair in secondary mitral regurgitation with restricted leaflet motion during systole
Conclusions Our study demonstrates the safety and feasibility of standardised subannular repair to treat ventricular SMR (Carpentier type IIIb) in a multicentre setting. By addressing mitral leaflet tethering, papillary muscle relocation results in very satisfactory 1-year outcomes and has the potential to durably restore MV geometry; nevertheless, long-term FU is mandatory. Trial registration number NCT03470155.
Source: Heart - August 24, 2023 Category: Cardiology Authors: Pausch, J., Harmel, E., Reichenspurner, H., Kempfert, J., Kuntze, T., Owais, T., Holubec, T., Walther, T., Krane, M., Vitanova, K., Borger, M. A., Eden, M., Hachaturyan, V., Bramlage, P., Falk, V., Girdauskas, E. Tags: Valvular heart disease Source Type: research